Nov 22 (Reuters) - Britain's competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order during its investigation into Theramex's acquisition of European rights to two of Viatris's women's healthcare product ranges.
The Competition and Markets Authority $(CMA)$ said Viatris breached regulations by failing to obtain its consent before altering key staff and by not reporting the breach.
($1 = 0.7978 pounds)
(Reporting by DhanushVignesh Babu in Bengaluru; Editing by Savio D'Souza)
((DhanushVignesh.Babu@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。